In conclusion, although our study was conducted in vitro and its generality in vivo must be demonstrated, we can suggest taking particular care in the interpretation of HuR expression levels and cell localization in cancer, since its downregulation could be expected to be an indicator of bad prognosis in tumors treated with doxo. This evidence concerns the gene ELAVL1 and cancer.